002773 Stock Overview Research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Chengdu Kanghong Pharmaceutical Group Co., Ltd Competitors Price History & Performance
Summary of share price highs, lows and changes for Chengdu Kanghong Pharmaceutical Group Historical stock prices Current Share Price CN¥19.60 52 Week High CN¥24.50 52 Week Low CN¥13.15 Beta 0.14 1 Month Change -4.30% 3 Month Change -8.58% 1 Year Change 6.12% 3 Year Change -7.55% 5 Year Change -49.16% Change since IPO -57.00%
Recent News & Updates
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Fiscal Year 2024 Results on Apr 26, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.33 in 3Q 2023) Oct 25
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27
Second quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.27 in 2Q 2023) Aug 23
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report First Half, 2024 Results on Aug 23, 2024 Jun 29 See more updates
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Fiscal Year 2024 Results on Apr 26, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.33 in 3Q 2023) Oct 25
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27
Second quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.27 in 2Q 2023) Aug 23
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report First Half, 2024 Results on Aug 23, 2024 Jun 29
Dividend increased to CN¥0.38 May 24
Investor sentiment improves as stock rises 19% May 01
Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023 Apr 27
Chengdu Kanghong Pharmaceutical Group Co., Ltd, Annual General Meeting, May 16, 2024 Apr 26
First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.30 in 1Q 2023) Apr 25
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Q1, 2024 Results on Apr 25, 2024 Mar 30
Investor sentiment improves as stock rises 19% Feb 12
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Fiscal Year 2023 Results on Apr 25, 2024 Dec 30
Investor sentiment improves as stock rises 15% Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.24 in 3Q 2022) Oct 27
Chengdu Kanghong Pharmaceutical Group Co., Ltd to Report Q3, 2023 Results on Oct 27, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.26 in 2Q 2022) Aug 28
Investor sentiment deteriorates as stock falls 16% Jul 21
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 6, 2023 May 31
Investor sentiment improves as stock rises 15% May 24
Insufficient new directors Jan 01
High number of new directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.25 in 3Q 2021) Oct 29
Investor sentiment improved over the past week Oct 19
Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021) Aug 24
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Cash Dividend for A Shares for the Year 2021, Payment date is 08 June 2022 Jun 01
Chengdu Kanghong Pharmaceutical Group Co. Ltd. Approves Cash Dividend for the Year 2021 May 24 Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2021 May 08
Chengdu Kanghong Pharmaceutical Group Co., Ltd, Annual General Meeting, May 20, 2022 May 07
First quarter 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.25 in 1Q 2021) May 02
High number of new directors Apr 27
Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.28 in 3Q 2020) Oct 28
High number of new directors Sep 29
Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.18 in 2Q 2020) Aug 30
Chengdu Kanghong Pharmaceuticals Group Co., Proposes Final Cash Dividend for the Year 2020 Apr 29
First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.20 in 1Q 2020) Apr 29
Investor sentiment deteriorated over the past week Apr 15
Investor sentiment deteriorated over the past week Mar 31
New 90-day low: CN¥35.28 Mar 16
Full year 2020 earnings released: EPS CN¥0.96 (vs CN¥0.82 in FY 2019) Mar 04
Revenue misses expectations Mar 04
Chengdu Kanghong Pharmaceutical Group Receives Special Protocol Assessments from the Food and Drug Administration for Three New Indications for Its Biologic Drug Conbercept Feb 04
New 90-day low: CN¥35.44 Feb 04
New 90-day low: CN¥39.81 Jan 19
Investor sentiment improved over the past week Dec 29
New 90-day high: CN¥47.89 Dec 28
Chengdu Kanghong Pharmaceuticals Group Co., Ltd Announces Completion 36-Week Primary Endpoint Visits of Phase Iii Trial of Conbercept Dec 24
Third quarter earnings released Oct 28
Third-quarter earnings released: Revenue misses expectations Oct 28
Chengdu Kanghong Pharmaceuticals Group Co., Ltd to Report Q3, 2020 Results on Oct 27, 2020 Oct 20
New 90-day low: CN¥42.93 Oct 16
New 90-day high - CN¥51.18 Sep 08
Earnings released Aug 26
Chengdu Kanghong Pharmaceuticals Group Co., Ltd to Report First Half, 2020 Results on Aug 26, 2020 Aug 10 Shareholder Returns 002773 CN Pharmaceuticals CN Market 7D -0.4% -0.08% 1.0% 1Y 6.1% -6.0% 8.2%
See full shareholder returns
Return vs Market: 002773 underperformed the CN Market which returned 8.2% over the past year.
Price Volatility Is 002773's price volatile compared to industry and market? 002773 volatility 002773 Average Weekly Movement 5.0% Pharmaceuticals Industry Average Movement 6.7% Market Average Movement 8.1% 10% most volatile stocks in CN Market 12.2% 10% least volatile stocks in CN Market 5.1%
Stable Share Price: 002773 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002773's weekly volatility (5%) has been stable over the past year.
About the Company Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs.
Show more Chengdu Kanghong Pharmaceutical Group Co., Ltd Fundamentals Summary How do Chengdu Kanghong Pharmaceutical Group's earnings and revenue compare to its market cap? 002773 fundamental statistics Market cap CN¥18.03b Earnings (TTM ) CN¥1.19b Revenue (TTM ) CN¥4.37b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 002773 income statement (TTM ) Revenue CN¥4.37b Cost of Revenue CN¥457.72m Gross Profit CN¥3.91b Other Expenses CN¥2.72b Earnings CN¥1.19b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 26, 2025
Earnings per share (EPS) 1.30 Gross Margin 89.53% Net Profit Margin 27.30% Debt/Equity Ratio 0%
How did 002773 perform over the long term?
See historical performance and comparison Dividends
1.9% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/31 20:44 End of Day Share Price 2024/12/31 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Chengdu Kanghong Pharmaceutical Group Co., Ltd is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Weiya Zhang BOCI Research Ltd. Yue Gao Changjiang Securities Co. LTD. Ziyu He China International Capital Corporation Limited
Show 11 more analysts 
